Skip to main content
Molecular Cancer logoLink to Molecular Cancer
. 2026 Aug 10;25:191. doi: 10.1186/s12943-026-02720-8

Editorial expression of concern: Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer

Yuanyuan Li 1,3,, Syed M Meeran 7, Shweta N Patel 6, Huaping Chen 1, Tabitha M Hardy 1, Trygve O Tollefsbol 1,2,3,4,5
PMCID: PMC13455321  PMID: 42572028

Correction: Mol Cancer 12, 9 (2013)

https://doi.org/10.1186/1476-4598-12-9; Published: 4 February 2013

The Editor-in-Chief would like to alert readers that concerns were raised regarding similarities of Acetyl-H3K9, Acetyl-H4, Dimethyl-H3K3, and Input band sections between Figs. 2A and 3A of another article [1].

The authors have provided original data that could not be sufficiently validated and maintain that this error does not affect the final results, findings, and conclusions. Therefore, readers are advised to interpret the data listed above with caution.

Author Trygve Tollefsbol has stated on behalf of all authors that they disagree to this EeoC.

References

  • 1.Li, Y., Yuan, YY., Meeran, S.M. et al. Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells. Mol Cancer 9, 274 (2010). 10.1186/1476-4598-9-274 [DOI] [PMC free article] [PubMed]

Articles from Molecular Cancer are provided here courtesy of BMC

RESOURCES